Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity

This publication has 20 references indexed in Scilit:

• Obesity and Oral Contraceptive Failure: Findings from the 2002 National Survey of Family Growth
  American Journal of Epidemiology, 2007
• Pharmacokinetics of single-dose levonorgestrel in adolescents
  Contraception, 2006
• Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001
  Perspectives on Sexual and Reproductive Health, 2006
• The Role of Body Weight in Oral Contraceptive Failure: Results from the 1995 National Survey of Family Growth
  Annals of Epidemiology, 2005
• Body Mass Index, Weight, and Oral Contraceptive Failure Risk
  Obstetrics & Gynecology, 2005
• THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL
  Drug Metabolism and Disposition, 2004
• Body weight and risk of oral contraceptive failure*1
  Obstetrics & Gynecology, 2002
• Pharmacokinetic Considerations in Obesity
  Journal of Pharmaceutical Sciences, 1999
• Levonorgestrel
  Clinical Pharmacokinetics, 1995
• Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration
  Contraception, 1975